HomeInsightsEPS

Glenmark Pharmaceuticals Ltd EPS

Glenmark Pharmaceuticals Ltd EPS

stocks purchased

₹ 1.5 Cr

Volume Transacted

(Dec 24, 2024)

stocks purchased

9.4 K

Stocks Traded

(Dec 24, 2024)

Last Updated on: Dec 25, 2024

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

EPS

₹ -70.31

Last updated on: Dec 24, 2024

Key Highlights

  • The Earning per Share of Glenmark Pharmaceuticals Ltd is ₹ -70.31 as of 24 Dec 24 .
  • The earning per share of Glenmark Pharmaceuticals Ltd changed from ₹ 6.82 to ₹ 12.55 over 10 quarters. This represents a CAGR of 27.63% .

Historical Earning per Share of Glenmark Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Glenmark Pharmaceuticals Ltd

Market Cap

43,348 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

5.1

Day’s High *

1562.05

Day’s Low

1530.0

DTE *

0.2

ROE *

-23.5

52 Week High

1830.05

52 Week Low

766.65

ROCE *

17.3

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Dec 20241536.15
23 Dec 20241549.95
20 Dec 20241542.35
19 Dec 20241540
18 Dec 20241524.2
17 Dec 20241512.6
16 Dec 20241551.4
13 Dec 20241517.2
12 Dec 20241534.5
11 Dec 20241526.1

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

43,348

Asset Value

8,478

4.1 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Glenmark Pharmaceuticals Ltd043,348
Sun Pharmaceuticals Industries Ltd464,36,103
Divis Laboratories Ltd691,53,540
Mankind Pharma Ltd511,20,073
Cipla Ltd571,19,196
Torrent Pharmaceuticals Ltd511,15,107

Historical Market Cap of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Lacosamide Oral Solu...

Read more

16 Dec 2024 09:06

News

Glenmark Pharma arm launches seizure drug in US

The newly launched drug is bioequivalent and therapeutically equivalent to the reference l...

Read more

16 Dec 2024 09:41

News

Glenmark Pharmaceuticals Ltd up for third straight session

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

03 Dec 2024 13:06

News

Glenmark Pharma launches Travoprost Ophthalmic Solution USP

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Travoprost Ophthalmi...

Read more

27 Nov 2024 09:12

News

Glenmark Pharma arm launches Travoprost Ophthalmic Solution in U.S market

Travoprost ophthalmic is used to treat glaucoma (a condition in which increased pressure i...

Read more

27 Nov 2024 09:59

News

Glenmark Pharmaceuticals Ltd eases for fifth straight session

Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...

Read more

18 Nov 2024 13:35

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

June 2024

TranscriptPPT

May 2024

PPT

Sep 2023

PPT

Feb 2022

PPT

Nov 2021

PPT

Aug 2021

PPT

May 2021

PPT

FAQs for EPS of Glenmark Pharmaceuticals Ltd

What is the EPS of Glenmark Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Glenmark Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Glenmark Pharmaceuticals Ltd EPS calculated?

The EPS of Glenmark Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Glenmark Pharmaceuticals Ltd report its EPS?

Glenmark Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Glenmark Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Glenmark Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Glenmark Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Glenmark Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions